Opus Genetics, Inc.
IRD
$0.8905
$0.02552.95%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -476.13% | -194.58% | -175.60% | -160.46% | -155.83% |
| Total Depreciation and Amortization | 66.67% | -25.00% | 0.00% | 25.00% | 50.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 502.17% | -28.67% | 33.66% | 117.46% | 142.39% |
| Change in Net Operating Assets | -24.19% | 201.26% | -523.44% | 176.34% | 173.38% |
| Cash from Operations | -2,200.00% | -158.75% | -152.98% | -118.90% | -107.77% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -51.42% | 50.89% | 876.36% | 264.47% | 107.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 16.55% | -203.39% | -684.78% | -235.64% | -112.21% |
| Cash from Financing | -53.38% | 46.76% | 879.86% | 291.01% | 137.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -356.51% | -120.07% | -93.76% | -58.60% | -56.54% |